Improving Symptoms in Young Men with Erectile Dysfunction: Testosterone Therapy With or Without PDE5 Inhibitors

被引：0
|
作者：
Song, J. [1 ]
Saffati, G. [1 ]
Naeem, T. [1 ]
Biles, B. [1 ]
Pierce, H. [1 ]
Lipshultz, L., I [1 ]
Khera, M. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2024年 / 21卷
关键词：
D O I：
10.1093/jsxmed/qdae001.151
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
160
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PDE 5 INHIBITORS MULTIDRUG THERAPY FOR ERECTILE DYSFUCTION - A RESCUE STRATEGY FOR PDE5 MONOTHERAPY NON RESPONDERS
    Ponnusamy, A. K.
    Vasan, S. S.
    Shashidhar, B.
    Karthik, K. N.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2017, 14 (01): : S122 - S122
  • [42] Patterns of PDE5 inhibitor use in patients with erectile dysfunction
    Katherine Sole
    [J]. Nature Clinical Practice Urology, 2006, 3 (1): : 6 - 6
  • [43] Mirodenafil: a new PDE5 inhibitor for the treatment of erectile dysfunction
    [J]. Nature Clinical Practice Urology, 2009, 6 (2): : 60 - 60
  • [44] Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study
    Maio, Giuseppe
    Saraeb, Salim
    Marchiori, Antonio
    [J]. JOURNAL OF SEXUAL MEDICINE, 2010, 7 (06): : 2201 - 2208
  • [45] Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
    Bi, YZ
    Stoy, P
    Adam, L
    He, B
    Krupinski, J
    Normandin, D
    Pongrac, R
    Seliger, L
    Watson, A
    Macor, JE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1577 - 1580
  • [46] Comparison of clinical efficacy and preference of three different PDE5 inhibitors for patients with erectile dysfunction
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 139 - 139
  • [47] Vardenafil improves satisfaction in couples affected by erectile dysfunction previously untreated with PDE5 inhibitors
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 177 - 177
  • [48] Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction
    Kim, Young Hoon
    Choi, Hojin
    Lee, Jaekwang
    Hwang, In-Chang
    Moon, Seung Kee
    Kim, Soo Jin
    Lee, Hong Woo
    Im, Dai Sig
    Lee, Sung Sook
    Ahn, Soon Kil
    Kim, Sang Woong
    Han, Cheol Kyu
    Yoon, Jeong Hyeok
    Lee, Kyung Joo
    Choi, Nam Song
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6279 - 6282
  • [49] Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction
    Yu, GX
    Mason, HJ
    Wu, XM
    Wang, J
    Chong, SH
    Dorough, G
    Henwood, A
    Pongrac, R
    Seliger, L
    He, B
    Normandin, D
    Adam, L
    Krupinski, J
    Macor, JE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) : 1025 - 1027
  • [50] WHAT IS THE OVERALL SAFETY AND EFFICACY OF INHIBITORS OF THE PHOSPHODIESTERASE TYPE 5 ENZYME (PDE5) IN THE TREATMENT OF ERECTILE DYSFUNCTION?
    Ezquer, A. J.
    Gilli, F. A.
    Cenice, F. F.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 89 - 89
12345